The following Corporation Tax guidance note by Tolley provides comprehensive and up to date tax information covering:
A relief similar to R&D relief is available for revenue expenditure incurred by large companies carrying out research into certain vaccines and medicines for specific strains of TB, malaria, HIV and AIDS. This relief will be abolished entirely from 1 April 2017 as discuss
Access this article and thousands of others like it free for 7 days with a trial of TolleyGuidance.
Read full article
Already a subscriber? Login